Clinical Trial Update: SPI-1005 Treatment in Severe COVID-19 Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for SPI-1005 in severe COVID-19 patients. Current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease

Drugs mentioned

• SPI-1005

Snippet

Sponsor: Sound Pharmaceuticals, Incorporated | Conditions: Covid19, Coronavirus | Phase 2 | Status: UNKNOWN